During the past decade, California Retina Consultants conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 26 clinical trials were completed, i.e. on average, 60.5% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 18 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "California Retina Consultants" #1 sponsor was "Hoffmann-La Roche" with 13 trials, followed by "Jaeb Center for Health Research" with 12 trials sponsored, "California Retina Consultants" with 9 trials sponsored, "Genentech, Inc." with 6 trials sponsored and "Apellis Pharmaceuticals, Inc." with 6 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "California Retina Consultants" #1 collaborator was "National Eye Institute (NEI)" with 12 trials as a collaborator, "Genentech, Inc." with 11 trials as a collaborator, "Allergan" with 5 trials as a collaborator, "Regeneron Pharmaceuticals" with 4 trials as a collaborator and "National Institutes of Health (NIH)" with 3 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "California Retina Consultants" are "Diabetic Macular Edema" (20 trials), "Geographic Atrophy" (13 trials), "Diabetic Retinopathy" (6 trials), "Macular Degeneration" (4 trials) and "Proliferative Diabetic Retinopathy" (4 trials). Many other conditions were trialed in "California Retina Consultants" in a lesser frequency.

Most popular intervention types in "California Retina Consultants" are "Drug" (52 trials), "Other" (14 trials), "Procedure" (8 trials), "Biological" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ranibizumab" (7 trials), "Sham Procedure" (7 trials), "Faricimab" (6 trials), "Lampalizumab" (5 trials) and "Placebo" (4 trials). Other intervention names were less common.

The vast majority of trials in "California Retina Consultants" are 63 trials for "All" genders.

Currently, there are NaN active trials in "California Retina Consultants". undefined are not yet recruiting, 3 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in California Retina Consultants, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in California Retina Consultants, 7 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".